{
    "Overall_score": {
        "Correlation": 8,
        "Sentiment": 7,
        "Importance": 9,
        "Impact": 8,
        "Duration": 6,
        "Virality": 4,
        "Source_Score": 7,
        "Specificity": 9,
        "Sector_Spread": 5,
        "Tech_Mentions": 3
    },
    "Each_item": [
        {
            "News_content": "AMGN Blincyto FDA accelerated app'l on P2 r/r adult ALL trial; 1' endpt=CR+CRh* rate (43%; mOS 6.1mo at ASCO2014) biotech leukemia",
            "Correlation": 9,
            "Sentiment": 7,
            "Importance": 8,
            "Impact": 7,
            "Duration": 5,
            "Virality": 3,
            "Source_Score": 6,
            "Specificity": 9,
            "Sector_Spread": 4,
            "Tech_Mentions": 2
        },
        {
            "News_content": "Nasdaq100 Stocks Performance TRIP BIIB ALXN NFLX REGN STX MXIM QCOM VRTX MU AMGN GILD SPLS",
            "Correlation": 5,
            "Sentiment": 5,
            "Importance": 4,
            "Impact": 4,
            "Duration": 3,
            "Virality": 5,
            "Source_Score": 6,
            "Specificity": 5,
            "Sector_Spread": 8,
            "Tech_Mentions": 1
        },
        {
            "News_content": "AMGN - FDA Approves BLINCYTOâ„¢ (Blinatumomab) Immunotherapy for the Treatment of Relapsed or Refractory",
            "Correlation": 9,
            "Sentiment": 8,
            "Importance": 10,
            "Impact": 9,
            "Duration": 7,
            "Virality": 5,
            "Source_Score": 8,
            "Specificity": 10,
            "Sector_Spread": 6,
            "Tech_Mentions": 4
        }
    ]
}